Novo Nordisk repurchased 1,055,000 B shares for DKK 314,100,478 between August 31 and September 4, 2026, at daily average prices ranging from DKK 291.92 to DKK 305.35. The purchases were made under a programme initiated on May 6 that allows repurchases of up to DKK 11,200,000,010.45 through February 1, 2027, as part of the company’s overall DKK 15 billion buyback programme covering the 12-month period beginning February 4, 2026. Including the latest transactions, 17,275,000 shares had been repurchased under the May programme for DKK 5,221,774,293. Since February 4, Novo Nordisk had repurchased 32,034,179 B shares for DKK 9,021,774,283 at an average price of DKK 281.63. The company held 46,074,876 B shares as treasury shares, equal to 1.0% of its share capital.